Detection and Delineation of Necrotizing Fasciitis Via a Vascular Perfusion Fluorophore
1 other identifier
observational
18
1 country
1
Brief Summary
The primary objective of this work is to determine if fluorescence signal intensity changes from a vascular perfusion fluorophore (indocyanine green) can be associated with the presence of necrotizing fasciitis. Hypothesis - Tissue regions affected with necrotizing fasciitis will demonstrate reduced fluorescence intensity compared to an unaffected region without clinical evidence of necrotizing fasciitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 5, 2021
CompletedFirst Submitted
Initial submission to the registry
April 8, 2021
CompletedFirst Posted
Study publicly available on registry
April 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 4, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 4, 2024
CompletedMay 23, 2025
May 1, 2025
3.7 years
April 8, 2021
May 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnosis of Necrotising Fascitis using indocyanine green
Administration of ICG and subsequent imaging of a bodily region affected with NF will demonstrate substantially reduced fluorescence compared to the patient's unaffected tissues. Demonstration that ICG fluorescence voids are characteristic of NF.
One Day
Study Arms (1)
Patients with possible nectrotizing fascitis
Patients with clinical suspicion of necrotizing fasciitis would receive a weight-appropriate IV dose of indocyanine green (ICG, FDA-approved) with immediate fluorescence imaging of the affected body part and simultaneous imaging of an unaffected region
Interventions
Patients with clinical suspicion of necrotizing fasciitis would receive a weight-appropriate IV dose of indocyanine green (ICG, FDA-approved) with immediate fluorescence imaging of the affected body part and simultaneous imaging of an unaffected region
Eligibility Criteria
Subjects presenting to the Emergency Department (ED) with clinical suspicion for necrotizing fasciitis (history, exam, lab studies, imaging studies).
You may qualify if:
- Age 18 years or older
- Clinical suspicion of necrotizing fasciitis based on physician or mid-level provider assessment. Clinical suspicion would be based upon the presence of one or more of these findings: Pain out of proportion to visible findings Temperature 100.4 F LRINEC (Laboratory Risk INdicator for NECrotizing fasciitis) score of ≥6 (https://pubmed.ncbi.nlm.nih.gov/15241098/) Tense soft tissues
- Determined to be a candidate for soft-tissue biopsy and/or surgical debridement by the on-call emergency department, orthopaedic, and/or general surgical trauma teams.
- The ability to give written informed consent
You may not qualify if:
- History of allergy to ICG and/or iodine
- Pregnant women or nursing mothers
- No comparator region available for imaging control
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dartmouth-Hitchock
Lebanon, New Hampshire, 03766, United States
Related Publications (3)
Solomon IH, Borscheid R, Laga AC, Askari R, Granter SR. Frozen sections are unreliable for the diagnosis of necrotizing soft tissue infections. Mod Pathol. 2018 Apr;31(4):546-552. doi: 10.1038/modpathol.2017.173. Epub 2017 Dec 15.
PMID: 29243739BACKGROUNDBetz CS, Zhorzel S, Schachenmayr H, Stepp H, Havel M, Siedek V, Leunig A, Matthias C, Hopper C, Harreus U. Endoscopic measurements of free-flap perfusion in the head and neck region using red-excited Indocyanine Green: preliminary results. J Plast Reconstr Aesthet Surg. 2009 Dec;62(12):1602-8. doi: 10.1016/j.bjps.2008.07.042. Epub 2008 Nov 25.
PMID: 19036663BACKGROUNDRay GS, Streeter SS, Bateman LM, Elliott JT, Henderson ER; NEFARIOUS Study Group. Real-time identification of life-threatening necrotizing soft-tissue infections using indocyanine green fluorescence imaging. J Biomed Opt. 2024 Jun;29(6):066003. doi: 10.1117/1.JBO.29.6.066003. Epub 2024 May 14.
PMID: 38745983DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric R Henderson, MD
Dartmouth-Hitchcock Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Orthopaedics
Study Record Dates
First Submitted
April 8, 2021
First Posted
April 9, 2021
Study Start
April 5, 2021
Primary Completion
December 4, 2024
Study Completion
December 4, 2024
Last Updated
May 23, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share